Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

F/up study to increase sample size at 3600 mg/day

Posted by JohnB on November 11, 1999, at 23:14:56

In reply to Re: Same Study, But , Yes, You are Missing the Point, posted by Rick on November 11, 1999, at 15:29:02

The sample size at 3600 mg/day was "insufficient" for the manufacturer to make claims with regards to efficacy at that specific dosage. Parke-Davis does not want to be "burned" by contradicting results from a broader fixed-dose follow-up controlled study, however unlikely that is to happen. The eventual goal is to obtain FDA approval to market Gabapentin for treament of social phobia. Further, there are some indications that slightly higher dosages, sucha as 4800 mg/day, may be even more effective.





Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:JohnB thread:14991